U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
LIRILUMAB
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
ANTI-KIR ANTIBODY
Preferred Name English
BMS-986015-01
Code English
IMMUNOGLOBULIN G4, ANTI-(HUMAN ANTIGEN RECEPTOR KIR (KILLER CELL IMMUNOGLOBULIN-LIKE)) (HUMAN MONOCLONAL ANTI-KIR(CHO) HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL ANTI-KIR(CHO) LIGHT CHAIN, DIMER
Systematic Name English
IPH-2102
Code English
IPH2102
Code English
LIRILUMAB [USAN]
Common Name English
lirilumab [INN]
Common Name English
BMS-986015
Code English
Lirilumab [WHO-DD]
Common Name English
BMS-98601501
Code English
Classification Tree Code System Code
NCI_THESAURUS C129822
Created by admin on Mon Mar 31 21:38:04 GMT 2025 , Edited by admin on Mon Mar 31 21:38:04 GMT 2025
NCI_THESAURUS C141144
Created by admin on Mon Mar 31 21:38:04 GMT 2025 , Edited by admin on Mon Mar 31 21:38:04 GMT 2025
NCI_THESAURUS C20401
Created by admin on Mon Mar 31 21:38:04 GMT 2025 , Edited by admin on Mon Mar 31 21:38:04 GMT 2025
Code System Code Type Description
DRUG BANK
DB11754
Created by admin on Mon Mar 31 21:38:04 GMT 2025 , Edited by admin on Mon Mar 31 21:38:04 GMT 2025
PRIMARY
ChEMBL
CHEMBL2109500
Created by admin on Mon Mar 31 21:38:04 GMT 2025 , Edited by admin on Mon Mar 31 21:38:04 GMT 2025
PRIMARY
CAS
1000676-41-4
Created by admin on Mon Mar 31 21:38:04 GMT 2025 , Edited by admin on Mon Mar 31 21:38:04 GMT 2025
PRIMARY
SMS_ID
100000174823
Created by admin on Mon Mar 31 21:38:04 GMT 2025 , Edited by admin on Mon Mar 31 21:38:04 GMT 2025
PRIMARY
WIKIPEDIA
Lirilumab
Created by admin on Mon Mar 31 21:38:04 GMT 2025 , Edited by admin on Mon Mar 31 21:38:04 GMT 2025
PRIMARY
INN
9415
Created by admin on Mon Mar 31 21:38:04 GMT 2025 , Edited by admin on Mon Mar 31 21:38:04 GMT 2025
PRIMARY
FDA UNII
S9XDI9W918
Created by admin on Mon Mar 31 21:38:04 GMT 2025 , Edited by admin on Mon Mar 31 21:38:04 GMT 2025
PRIMARY
USAN
ZZ-164
Created by admin on Mon Mar 31 21:38:04 GMT 2025 , Edited by admin on Mon Mar 31 21:38:04 GMT 2025
PRIMARY
NCI_THESAURUS
C103820
Created by admin on Mon Mar 31 21:38:04 GMT 2025 , Edited by admin on Mon Mar 31 21:38:04 GMT 2025
PRIMARY
ACTIVE MOIETY
LIRILUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966